| Salivary Gland Squamous Cell Carcinoma studied in …STUDIED_INderived28 of 28show fewer |
|---|
| → studied in | NCT00588770Phase 3 · active not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576091Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939627Phase 2 · completed Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02245100completed Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01847326Phase 1 · completed Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01332279Phase 1 · withdrawn Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03032250NA · completed Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01816984Phase 1/Phase 2 · completed PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01249443Phase 1 · terminated Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01044433Phase 2 · completed Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254617Phase 1 · completed Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01469429Phase 1/Phase 2 · completed Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055913Phase 1/Phase 2 · completed Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02035527Phase 1 · completed Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01316757Phase 2 · completed Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01256385Phase 2 · completed Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01283178Phase 1 · terminated Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01528137Phase 1 · terminated Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458978Phase 2 · completed Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114283Phase 2 · completed Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01334177Phase 1 · completed TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00507767Phase 2 · completed Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098631Phase 2 · completed Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055770Phase 1/Phase 2 · completed Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00906360Phase 1 · terminated Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096512Phase 2 · completed S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033618Phase 2 · completed Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081211Phase 1 · terminated Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck · condition mapped ONTOLOGY_EXACT · 28 trials mapped (2 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |